2020 ASCO Virtual Direct™ Highlights


 

2020 Update on Esophagogastric Cancers: Did T-DXd Demonstrate Meaningful Clinical Improvements in ORR and OS vs. SoC Chemo in HER2+ Advanced Gastric/GEJ Cancer? Does the Addition of Ramucirumab to Perioperative FLOT Improve R0-resection Rates?

0 views
August 13, 2020
Comments 0
Login to view comments. Click here to Login